Cargando…
Lymphedema Prevalence and Treatment Benefits in Cancer: Impact of a Therapeutic Intervention on Health Outcomes and Costs
BACKGROUND: Lymphedema is a common complication of cancer therapeutics; its prevalence, treatment outcomes, and costs have been poorly defined. The objective of this study was to examine lymphedema prevalence among cancer survivors and to characterize changes in clinical outcomes and costs associate...
Autores principales: | Brayton, Kimberly M., Hirsch, Alan T., O′Brien, Patricia J., Cheville, Andrea, Karaca-Mandic, Pinar, Rockson, Stanley G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255037/ https://www.ncbi.nlm.nih.gov/pubmed/25470383 http://dx.doi.org/10.1371/journal.pone.0114597 |
Ejemplares similares
-
Lymphedema self-care: economic cost savings and opportunities to improve adherence
por: Karaca-Mandic, Pinar, et al.
Publicado: (2023) -
A non-randomized, open-label study of the safety and effectiveness of a novel non-pneumatic compression device (NPCD) for lower limb lymphedema
por: Rockson, Stanley G., et al.
Publicado: (2022) -
Author Correction: A non-randomized, open-label study of the safety and effectiveness of a novel non-pneumatic compression device (NPCD) for lower limb lymphedema
por: Rockson, Stanley G., et al.
Publicado: (2023) -
Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, an Open-Label Controlled Study
por: Rockson, Stanley G., et al.
Publicado: (2022) -
Experimental Lymphedema: Can Cellular Therapies Augment the Therapeutic Potential for Lymphangiogenesis?
por: Rockson, Stanley G.
Publicado: (2012)